Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.
Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.
复制标题
DOI:
10.1016/j.addr.2016.03.005
复制
发表时间:
2016-08-01
影响因子:
16.1
通讯作者:
Shankar P
中科院分区:
文献类型:
--
作者:
Swamy MN;Wu H;Shankar P
RNA interference (RNAi) provides a powerful tool to silence specific gene expression and has been widely used to suppress host factors such as CCR5 and/or viral genes involved in HIV-1 replication. Newer nuclease-based gene-editing technologies, such as zinc finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN) and the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, also provide powerful tools to ablate specific genes. Because of differences in co-receptor usage and the high mutability of the HIV-1 genome, a combination of host factors and viral genes needs to be suppressed for effective prevention and treatment of HIV-1 infection. Whereas the continued presence of small interfering/short hairpin RNA (si/shRNA) mediators is needed for RNAi to be effective, the continued expression of nucleases in the gene-editing systems is undesirable. Thus, RNAi provides the only practical way for expression of multiple silencers in infected and uninfected cells, which is needed for effective prevention/treatment of infection. There have been several advances in the RNAi field in terms of si/shRNA design, targeted delivery to HIV-1 susceptible cells, and testing for efficacy in preclinical humanized mouse models. Here, we comprehensively review the latest advances in RNAi technology towards prevention and treatment of HIV-1.
影响因子:
14.9
作者:
Li, Zhen;Fortin, Yves;Shen, Shi-Hsiang
通讯作者:
Shen, Shi-Hsiang